T-Cell Acute Lymphocytic Leukemia: Clinical Trials

3 trials for T-Cell Acute Lymphocytic Leukemia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting, 1 withdrawn. 3 Phase 1, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 13Recruiting 2, Withdrawn 1
Phase 23Recruiting 2, Withdrawn 1

Follow T-Cell Acute Lymphocytic Leukemia: new trials by email Literature Review of T-Cell Acute Lymphocytic Leukemia trials Research Report on T-Cell Acute Lymphocytic Leukemia

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Multicenter, Open-Label, Non-Randomized, Single-Arm Clinical Study of Nanobody CD5-CAR T Cell Therapy for Refractory/Relapsed T Lymphocyte Malignancies
Autologous CD5 CAR T-cells, Previous stem-cell transplantation (SCT) donor-derived CD5 CAR T-cells, Newly matched donor-derived CD5 CAR T-cells - T-Cell Acute Lymphocytic Leukemia, Acute Lymphoblastic Leukemia, in Relapse
Phase 1 / Phase 2RecruitingBeijing GoBroad Hospital542025-07-092025-11-26
CD5 Chimeric Antigen Receptor (CAR) T Cells in Subjects With Relapsed or Refractory T-cell Malignancies
Autologous CD5 CAR T-cells, Previous stem-cell transplantation (SCT) donor-derived CD5 CAR T-cells, Newly matched donor-derived CD5 CAR T-cells - T-Cell Acute Lymphocytic Leukemia, Acute Lymphoblastic Leukemia, in Relapse
Phase 1 / Phase 2RecruitingBeijing GoBroad Hospital542024-06-182026-03-10
A Clinical Study of CAR-T Treating Relapsed or Refractory T Cell Lymphoblastic Acute Leukemia/ Lymphoma
CD7 CAR-T - T-Cell Acute Lymphocytic Leukemia
Phase 1 / Phase 2WithdrawnGuangzhou Bio-gene Technology Co., Ltd2023-05-012026-03-17

Narrower conditions

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (3)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (2)

Broader conditions

Hematologic Diseases (3)  ·  Hemic and Lymphatic Diseases (3)  ·  Immune System Diseases (3)  ·  Immunoproliferative Disorders (3)  ·  Leukemia (3)  ·  Leukemia, Lymphoid (3)  ·  Lymphatic Diseases (3)  ·  Lymphoproliferative Disorders (3)  ·  Neoplasms (3)  ·  Neoplasms by Histologic Type (3)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)

Sponsors

Beijing GoBroad Hospital (2)  ·  Guangzhou Bio-gene Technology Co., Ltd (1)

Countries

China (3)

Top investigators

Junfang Yang, Bachelor (1)